- Building an Innovative Life Sciences Company' CEO Mark Duxon talks at the next OBN digital event 12th May 1pm-2pm, see news page.
- CEO Mark Duxon interviewed by The Pharma Letter on impact of Brexit on CROs...
- Announcing new premises in Poland with a focus on neuropsychiatric disorders...
- State-of-the-art premises opening this month at Discovery Park in Kent...
- Newly published work in Frontiers in Psychiatry demonstrating
- the effectiveness of a clinically relevant dose of ketamine...
- Head to 2021 conferences page to see titles of abstracts...
Login
- You are here:
-
Home
- Login
Our clients are our partners.
We work hard around the globe to create breakthrough results for them.
Start a Conversation
+48 515 244 120
Copyright
Copyright © 2019 Transpharmation Ltd. All Rights Reserved. Website created by Identity Ipswich Web Design